| enVVeno Medical is a med-tech company focused on improving the standard of care in the treatment of venous disease. Co. is developing tissue-based solutions that are designed to be life sustaining or life enhancing for patients with Chronic Venous Insufficiency (CVI). CVI occurs when valves inside of the veins of the leg fail, resulting in insufficient blood being returned to the heart. Co.'s primary product is a porcine based device to be surgically implanted in the deep venous system of the leg and is called the VenoValve®. In addition to the VenoValve, Co. has a second product in the early stages of development called enVVe. We show 5 historical shares outstanding datapoints in our coverage of NVNO's shares outstanding history.|
Understanding the changing numbers of NVNO shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NVNO versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NVNO by allowing them to research NVNO shares outstanding history
as well as any other stock in our coverage universe.